SEC EDGAR Filing Information

Form 8-K -- Current report

Period of Report: 2009-03-10
Filing Date Changed: 2009-03-16
Documents: 4
SEC Accession No.
0000812796-09-000012
Filing date: 2009-03-16
Accepted: 2009-03-16 16:36:09
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq Type Document Size Description
1 8-K dor8klapointehamilton.htm 32350 8K FOR NEW DIRECTOR LAPOINTE AND OFFICER HAMILTON
2 EX-10.1 hamiltonemploymentagreement.htm 54762 HAMILTON EMPLOYMENT AGREEMENT
3 EX-99.1 pressreleaselapointe.htm 14309 PRESS RELEASE FOR LAPOINTE
4 EX-99.2 pressreleasehamilton.htm 16535 PRESS RELEASE FOR HAMILTON
0000812796-09-000012.txt 119780 Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 09684820
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628
609-538-8200
 Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628